Quick Answer
Biofrontera Inc. reported Operating Income of -$11.35 million for fiscal year 2025.
Biofrontera Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$11.35M | +34.1% |
| 2024 | -$17.21M | +24.1% |
| 2023 | -$22.68M | -22.0% |
| 2022 | -$18.58M | +26.3% |
| 2021 | -$25.20M | -162.3% |
| 2020 | -$9.61M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$6.28M | -26.6% | -23.6% |
| June 30, 2025 | -$5.08M | -0.2% | -11.7% |
| March 31, 2025 | -$4.55M | +16.8% | +8.3% |
| September 30, 2024 | -$4.96M | -7.4% | +2.2% |
| June 30, 2024 | -$5.07M | +41.7% | +7.2% |
| March 31, 2024 | -$5.47M | +0.5% | -18.3% |
| September 30, 2023 | -$4.62M | -27.0% | +46.9% |
| June 30, 2023 | -$8.70M | -40.0% | -58.4% |
- Biofrontera Inc. showed an increase of +34.1% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, Biofrontera Inc.’s operating income has declined by 18.1% (from -$9.61 million to -$11.35 million).
- The most recent figure is from Biofrontera Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: